Prosecution Insights
Last updated: April 17, 2026
Application No. 19/054,790

COMPREHENSIVE INTRAOCULAR VISION ADVANCEMENT

Non-Final OA §102§112§DP
Filed
Feb 15, 2025
Examiner
LOPEZ, LESLIE ANN
Art Unit
3774
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
unknown
OA Round
1 (Non-Final)
65%
Grant Probability
Moderate
1-2
OA Rounds
3y 7m
To Grant
98%
With Interview

Examiner Intelligence

Grants 65% of resolved cases
65%
Career Allow Rate
412 granted / 635 resolved
-5.1% vs TC avg
Strong +34% interview lift
Without
With
+33.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
48 currently pending
Career history
683
Total Applications
across all art units

Statute-Specific Performance

§101
1.2%
-38.8% vs TC avg
§103
34.4%
-5.6% vs TC avg
§102
26.8%
-13.2% vs TC avg
§112
26.1%
-13.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 635 resolved cases

Office Action

§102 §112 §DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . The first inventor to file provisions of the Leahy-Smith America Invents Act (AIA ) apply to any application for patent, and to any patent issuing thereon, that contains or contained at any time— (A) a claim to a claimed invention that has an effective filing date on or after March 16, 2013 wherein the effective filing date is: (i) if subparagraph (ii) does not apply, the actual filing date of the patent or the application for the patent containing a claim to the invention; or (ii) the filing date of the earliest application for which the patent or application is entitled, as to such invention, to a right of priority under 35 U.S.C. 119, 365(a), or 365(b) or to the benefit of an earlier filing date under 35 U.S.C. 120, 121, or 365(c); or (B) a specific reference under 35 U.S.C. 120 , 121, or 365(c), to any patent or application that contains or contained at any time a claim as defined in paragraph (A), above. In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Status of the Claims Claim(s) 1-21 is/are pending. Claim(s) 1-18 are withdrawn. Election/Restriction Restriction to one of the following inventions is required under 35 U.S.C. 121: I. Claims 1-13, drawn to an intraocular device that sends a signal from a wireless transmitter on an intraocular implant body, classified in A61F 2/14. II. Claims 14-18, drawn to an oral input device in combination with an intraocular implant body and having a wireless transmitter in the mouth, classified in A61F 2/14. III. Claims 19-21, drawn to an oral input device with a wireless transmitter located on teeth, classified in A61F 9/08. The inventions are independent or distinct, each from the other because: Inventions II and I are related as combination and subcombination. Inventions in this relationship are distinct if it can be shown that (1) the combination as claimed does not require the particulars of the subcombination as claimed for patentability, and (2) that the subcombination has utility by itself or in other combinations (MPEP § 806.05(c)). In the instant case, the combination as claimed does not require the particulars of the subcombination as claimed because the combination requires the digital input signal to be from an oral input device, whereas the combination only requires a digital input signal and has no requirement it be from an oral device. The subcombination has separate utility such as being able to receive a digital input signal from any device, such as an external computer system. The examiner has required restriction between combination and subcombination inventions. Where applicant elects a subcombination, and claims thereto are subsequently found allowable, any claim(s) depending from or otherwise requiring all the limitations of the allowable subcombination will be examined for patentability in accordance with 37 CFR 1.104. See MPEP § 821.04(a). Applicant is advised that if any claim presented in a divisional application is anticipated by, or includes all the limitations of, a claim that is allowable in the present application, such claim may be subject to provisional statutory and/or nonstatutory double patenting rejections over the claims of the instant application. Inventions I and III are directed to related products. The related inventions are distinct if: (1) the inventions as claimed are either not capable of use together or can have a materially different design, mode of operation, function, or effect; (2) the inventions do not overlap in scope, i.e., are mutually exclusive; and (3) the inventions as claimed are not obvious variants. See MPEP § 806.05(j). In the instant case, the inventions as claimed the inventions as claimed have a materially different design, mode of operation, function, or effect. Here, Group I is an intraocular device having an intraocular implant body and lens arrays, where the device receives a signal to project an image on the user’s retina. Group II is a device that is able to send a signal to another device. Furthermore, the inventions as claimed do not encompass overlapping subject matter and there is nothing of record to show them to be obvious variants. Inventions II and III are related as combination and subcombination. Inventions in this relationship are distinct if it can be shown that (1) the combination as claimed does not require the particulars of the subcombination as claimed for patentability, and (2) that the subcombination has utility by itself or in other combinations (MPEP § 806.05(c)). In the instant case, the combination as claimed does not require the particulars of the subcombination as claimed because the combination does not require the oral input device be placed on the teeth specifically. The subcombination has separate utility such as being able to send a signal to a computer to collect data on a patient or send the signal to an implant other than an eye implant. The examiner has required restriction between combination and subcombination inventions. Where applicant elects a subcombination, and claims thereto are subsequently found allowable, any claim(s) depending from or otherwise requiring all the limitations of the allowable subcombination will be examined for patentability in accordance with 37 CFR 1.104. See MPEP § 821.04(a). Applicant is advised that if any claim presented in a divisional application is anticipated by, or includes all the limitations of, a claim that is allowable in the present application, such claim may be subject to provisional statutory and/or nonstatutory double patenting rejections over the claims of the instant application. Restriction for examination purposes as indicated is proper because all the inventions listed in this action are independent or distinct for the reasons given above and there would be a serious search and/or examination burden if restriction were not required because one or more of the following reasons apply: The inventions require a different field of search (e.g. searching different classes/subclasses or electronic resources, or employing different search strategies or search queries). Applicant is advised that the reply to this requirement to be complete must include (i) an election of an invention to be examined even though the requirement may be traversed (37 CFR 1.143) and (ii) identification of the claims encompassing the elected invention. The election of an invention may be made with or without traverse. To reserve a right to petition, the election must be made with traverse. If the reply does not distinctly and specifically point out supposed errors in the restriction requirement, the election shall be treated as an election without traverse. Traversal must be presented at the time of election in order to be considered timely. Failure to timely traverse the requirement will result in the loss of right to petition under 37 CFR 1.144. If claims are added after the election, applicant must indicate which of these claims are readable upon the elected invention. Should applicant traverse on the ground that the inventions are not patentably distinct, applicant should submit evidence or identify such evidence now of record showing the inventions to be obvious variants or clearly admit on the record that this is the case. In either instance, if the examiner finds one of the inventions unpatentable over the prior art, the evidence or admission may be used in a rejection under 35 U.S.C. 103 or pre-AIA 35 U.S.C. 103(a) of the other invention. This application contains claims directed to the following patentably distinct species. Upon election of any of Groups I-III, a further election must be made from the following species of signal receiving location Species 1-1: the retina (e.g. claim 1) Species 1-2: a projector (e.g. claim 7) The species are independent or distinct because each species within its group is of a different design than the other species within its group. Here, Species 1-1 sends the signal directly to the retina, where Species 1-2 sends the signal to a projector. In addition, these species are not obvious variants of each other based on the current record. Applicant is required under 35 U.S.C. 121 to elect a single disclosed species, or a single grouping of patentably indistinct species, for prosecution on the merits to which the claims shall be restricted if no generic claim is finally held to be allowable. Currently, none are generic. There is a serious search and/or examination burden for the patentably distinct species as set forth above because at least the following reason(s) apply: The species require a different field of search (e.g. searching different classes/subclasses or electronic resources, or employing different search strategies or search queries). Applicant is advised that the reply to this requirement to be complete must include (i) an election of a species to be examined even though the requirement may be traversed (37 CFR 1.143) and (ii) identification of the claims encompassing the elected species or grouping of patentably indistinct species, including any claims subsequently added. An argument that a claim is allowable or that all claims are generic is considered nonresponsive unless accompanied by an election. The election may be made with or without traverse. To preserve a right to petition, the election must be made with traverse. If the reply does not distinctly and specifically point out supposed errors in the election of species requirement, the election shall be treated as an election without traverse. Traversal must be presented at the time of election in order to be considered timely. Failure to timely traverse the requirement will result in the loss of right to petition under 37 CFR 1.144. If claims are added after the election, applicant must indicate which of these claims are readable on the elected species or grouping of patentably indistinct species. Should applicant traverse on the ground that the species, or groupings of patentably indistinct species from which election is required, are not patentably distinct, applicant should submit evidence or identify such evidence now of record showing them to be obvious variants or clearly admit on the record that this is the case. In either instance, if the examiner finds one of the species unpatentable over the prior art, the evidence or admission may be used in a rejection under 35 U.S.C. 103 or pre-AIA 35 U.S.C. 103(a) of the other species. Upon the allowance of a generic claim, applicant will be entitled to consideration of claims to additional species which depend from or otherwise require all the limitations of an allowable generic claim as provided by 37 CFR 1.141. During a telephone conversation with Matthew Cox on 4/9/2025 a provisional election was made without traverse to prosecute the invention of Group III and Species 1-1, claims 19-21. Affirmation of this election must be made by applicant in replying to this Office action. Claims 1-18 are withdrawn from further consideration by the examiner, 37 CFR 1.142(b), as being drawn to a non-elected invention. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 20-21 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 20 recites “The device”. It is unclear which device is being referred back to: “implant device” or “oral input device”. For purposes of examination the Examiner considers this language to be “The implant device”. Claim 21 recites the limitation "The apparatus". There is insufficient antecedent basis for this limitation in the claim. For purposes of examination the Examiner notes this language is being interpreted as “The oral implant device”. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 19-21 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Ghovanloo, et al (Ghovanloo) (US 2010/0007512 A1). Regarding Claim 19, Ghovanloo teaches an oral implant device (e.g. abstract, Figure 2, [0056], #10), comprising: an oral input device (e.g. [0056], #12) configured to be disposed on one or more teeth (e.g. [00556], Figures 3A-3B, 6), the oral input device configured to transmit a digital input signal in response to being manipulated (e.g. [0056], via wireless transmitter #20); and a power supply (e.g. Figure 6, [0058], power management circuitry including a battery) disposed on the oral input device (e.g. [0058], part of element #12) and operable to provide power to one or more components disposed on the oral input device (e.g. [0058]). Regarding Claim 20, there is a sensing object (e.g. [0052], #22) configured to be disposed on a tongue (e.g. [0052]), wherein the oral input device is further configured to generate the digital input signal in response to the sensing object being within a pre-determined proximity of the oral input device or at a location relative to the oral input device (e.g. [0052]). Regarding Claim 21, there is an external processing device (e.g. [0056], the component outside the mouth – the appliance control unit, #14) with a receiver (e.g. [0057], wirelessly communicates with #12) operable to wirelessly receive the digital input signal from the oral input device (e.g. [0057]). Relevant Prior Art JP 2020 014770 A teaches an oral implant device placed on a tooth as claimed, but is not prior art. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to LESLIE A LOPEZ whose telephone number is (571)270-7044. The examiner can normally be reached 8:30 AM - 5:30 PM, MST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jerrah Edwards can be reached on (408) 918-7557. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LESLIE A LOPEZ/Primary Examiner, Art Unit 3774 4/11/2025
Read full office action

Prosecution Timeline

Feb 15, 2025
Application Filed
Apr 15, 2025
Non-Final Rejection — §102, §112, §DP
Oct 16, 2025
Response after Non-Final Action
Oct 16, 2025
Response Filed

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599479
Heart Valve Comprising A Crown Piece Interconnected To Leaflets, A Top Cuff And A Bottom Cuff; And A Medical Implant
2y 5m to grant Granted Apr 14, 2026
Patent 12599475
ACCOMMODATING INTRAOCULAR LENSES AND METHODS OF MANUFACTURING
2y 5m to grant Granted Apr 14, 2026
Patent 12599482
DEVICE, SYSTEM, AND METHOD FOR TRANSCATHETER TREATMENT OF VALVULAR REGURGITATION WITH SECONDARY ANCHORS
2y 5m to grant Granted Apr 14, 2026
Patent 12599491
Biliary Stent
2y 5m to grant Granted Apr 14, 2026
Patent 12594162
CARDIAC VALVE REPAIR DEVICES WITH ANNULOPLASTY FEATURES AND ASSOCIATED SYSTEMS AND METHODS
2y 5m to grant Granted Apr 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
65%
Grant Probability
98%
With Interview (+33.6%)
3y 7m
Median Time to Grant
Low
PTA Risk
Based on 635 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in for Full Analysis

Enter your email to receive a magic link. No password needed.

Free tier: 3 strategy analyses per month